Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polaprezinc granules vs omeprazole for gastric ulcer
CTR20132063Phase 2Active
- Sponsor
- Sichuan Beidaer New Technology Development
- Start
- Mar 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of polaprezinc in gastric ulcer, sponsored by Sichuan Beidaer New Technology Development. Started Mar 2014; status: active.
02
Drugs
polaprezinc
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on CTR20132063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132063.